Kisspeptin 10mg

For research use only — not for human or veterinary use.

Analytical Verification (COA)

Each batch of Kisspeptin supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety.

Analytical testing for this batch was performed by Liquilabs s.r.o. (Czechia) using validated chromatographic and spectrometric techniques.

Batch: GF082025005

Key analytical results include:

• Assay Content: 10.23 mg
• Identification – Retention Time: 0.993
• Identification – Spectrum: 991
• Purity: greater than 99.8 percent
• Bacterial Endotoxins: below 0.001 EU per mg
• Total Aerobic Microbial Count: not detected
• Total Yeast and Mold Count: not detected

Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium.

These analytical procedures ensure traceability, purity verification and laboratory-grade compound consistency.

Product Overview

Kisspeptin is a synthetic peptide frequently studied in controlled laboratory environments investigating neuroendocrine signalling pathways and receptor-mediated regulatory systems.

The compound belongs to a class of peptide signalling molecules involved in experimental models examining hypothalamic signalling networks and endocrine regulatory mechanisms.

This preparation contains 10 mg of high purity lyophilized peptide supplied in a sealed research vial. The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation.

Because of its defined peptide structure and stable analytical profile, Kisspeptin has become a widely referenced compound in experimental research models studying neuroendocrine signalling pathways.

Compound Overview

Kisspeptin refers to a group of peptides derived from the KISS1 gene that function as signalling molecules in neuroendocrine regulatory systems.

In biochemical research environments, Kisspeptin peptides are frequently examined for their interaction with the G protein–coupled receptor known as GPR54 (also called the Kisspeptin receptor).

This receptor-mediated signalling pathway plays a role in complex endocrine communication networks and hypothalamic regulatory mechanisms.

Because of its interaction with these signalling systems, Kisspeptin peptides are widely studied in laboratory research exploring neuroendocrine communication and receptor-mediated regulatory pathways.

Historical Background and Scientific Context

The discovery of the KISS1 gene during cancer research in the 1990s led to the identification of Kisspeptin peptides as signalling molecules with broader biological relevance.

Subsequent molecular biology research revealed that Kisspeptin plays a significant role in neuroendocrine signalling pathways within the hypothalamus.

As interest in neuroendocrine regulation expanded, researchers began investigating Kisspeptin peptides in experimental models studying receptor signalling and endocrine communication systems.

Since that time, Kisspeptin peptides have become widely referenced in biochemical and neuroendocrine research exploring hormone signalling networks.

Mechanistic Focus in Research

Within experimental laboratory environments, Kisspeptin is often studied in relation to neuroendocrine signalling pathways and receptor-mediated communication systems.

Research investigations commonly explore the compound in experimental models examining:

• Kisspeptin receptor (GPR54) signalling pathways
• Neuroendocrine regulatory mechanisms
• Hypothalamic signalling networks
• Peptide-mediated endocrine communication
• Intracellular signalling pathway modelling
• Comparative peptide signalling studies
• Endocrine system regulatory networks

These experimental models allow scientists to investigate molecular signalling systems that influence endocrine communication and neuroendocrine regulation.

Research Applications

In controlled research environments, Kisspeptin may be utilised in experimental models designed to explore neuroendocrine signalling and receptor-mediated regulatory pathways.

Examples of research applications include:

• Neuroendocrine signalling pathway investigation
• Peptide-receptor interaction research
• Hypothalamic signalling studies
• Endocrine regulatory pathway modelling
• Comparative peptide signalling research
• Intracellular signalling network analysis
• Controlled in vitro neuroendocrine studies

Grail Formula Quality

Every Grail Formula research compound is produced under strict quality control procedures designed to support reliable laboratory experimentation.

Each batch undergoes independent analytical testing to verify:

• Compound identity
• Assay accuracy
• Purity confirmation
• Microbial safety
• Endotoxin levels
• Heavy metal screening
• Full batch traceability

All testing is performed by independent laboratories to ensure transparent verification and reproducible research material.

Research Use Limitation

• Used solely for in vitro experiments
• Not permitted for clinical trials involving humans
• Not permitted for human or veterinary administration
• Not permitted for investigational human use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF082025005 – Published October 2025
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.